Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine Add-on to Sodium Valproate in Childhood Epilepsy
NCT05881928Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jul 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of lamotrigine in epilepsy, sponsored by Assiut University. Primary endpoint: Body Weight at 6 months. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05881928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05881928.